{"id":55659,"date":"2023-04-11T11:03:10","date_gmt":"2023-04-11T09:03:10","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/u-s-nuclear-medicine-market-outlook-report-2022-2024-featuring-siemens-ge-philips-canon-digirad-spectrum-dynamics-and-more-researchandmarkets-com\/"},"modified":"2023-04-11T11:03:10","modified_gmt":"2023-04-11T09:03:10","slug":"u-s-nuclear-medicine-market-outlook-report-2022-2024-featuring-siemens-ge-philips-canon-digirad-spectrum-dynamics-and-more-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/u-s-nuclear-medicine-market-outlook-report-2022-2024-featuring-siemens-ge-philips-canon-digirad-spectrum-dynamics-and-more-researchandmarkets-com\/","title":{"rendered":"U.S Nuclear Medicine Market Outlook Report 2022-2024 Featuring Siemens, GE, Philips, Canon, Digirad, Spectrum Dynamics and more &#8211; ResearchAndMarkets.com"},"content":{"rendered":"<div>\n<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5758407\/u-s-nuclear-medicine-market-outlook-report?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=3wr5ql&amp;utm_campaign=1837970+-+U.S+Nuclear+Medicine+Market+Outlook+Report+2022-2024+Featuring+Siemens%2C+GE%2C+Philips%2C+Canon%2C+Digirad%2C+Spectrum+Dynamics+and+more&amp;utm_exec=shbe20prd\" rel=\"nofollow noopener\" shape=\"rect\">&#8220;2022 U.S Nuclear Medicine Market Outlook Report&#8221;<\/a> report has been added to <strong>ResearchAndMarkets.com&#8217;s<\/strong> offering.<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20230411005547\/en\/1760504\/4\/logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20230411005547\/en\/1760504\/21\/logo.jpg\"><\/a><\/p>\n<p>\nThe 2022 Nuclear Medicine Market Outlook examines nuclear medicine procedure volumes, purchase plans, and buying criteria for future nuclear medicine purchases. Learn how NM administrators feel about their department&#8217;s future outlook and how they prioritize their goals in light of industry challenges.<\/p>\n<p>\nThe report explores nuclear medicine market trends, including NM procedure volume, installed base features, use of OEM vs. third-party service providers, equipment purchase plans, contrast utilization\/budgets, NM power injectors, and site operations characteristics. Survey results are projected to the identified universe of NM facilities, and the report provides market forecast scenarios for NM scanners for 2022-2024.<\/p>\n<p>\n<strong>What you&#8217;ll learn in this report<\/strong><\/p>\n<p>\n<strong>Nuclear medicine department priorities and future outlook<\/strong><\/p>\n<ul>\n<li>\nWhat are the key department priorities for NM?<\/li>\n<li>\nWhat factors will impact the outlook for NM the most?<\/li>\n<li>\nWhat are the preferred info sources for future NM purchases?<\/li>\n<li>\nWhat are the top-ranked preferred uses of AI for NM?<\/li>\n<\/ul>\n<p>\n<strong>Nuclear medicine procedures<\/strong><\/p>\n<ul>\n<li>\nHow has NM volume changed in 2021?<\/li>\n<li>\nWhat is the trend in NM procedure mix by procedure type?<\/li>\n<\/ul>\n<p>\n<strong>NM scanner installed base and purchase plans<\/strong><\/p>\n<ul>\n<li>\nHow many fixed NM units are installed by site type?<\/li>\n<li>\nWhat is the trend in installed base market share by vendor?<\/li>\n<li>\nWhat is the adoption rate for key NM capabilities?<\/li>\n<li>\nWhat is the anticipated age of NM units upon replacement?<\/li>\n<li>\nWhat is the mix of new vs. refurbished NM scanners?<\/li>\n<li>\nWhat type of service providers are NM sites using?<\/li>\n<li>\nWhat is the brand loyalty of current NM users?<\/li>\n<li>\nWhat are the key buying criteria for future NM scanners?<\/li>\n<li>\nWhat is the unit forecast for NM scanners for 2022 to 2024?<\/li>\n<\/ul>\n<p>\n<strong>Site operations characteristics<\/strong><\/p>\n<ul>\n<li>\nHow many technologists, nurses, administrators, imaging aides, and secretaries are employed in NM departments?<\/li>\n<li>\nWhat % of sites &amp; procedures use outside reading services<\/li>\n<\/ul>\n<p>\n2022 Nuclear Medicine department procedure volumes are expected to increase but reimbursement, revenue and net income are expected to stay the same, according to the 2022 Nuclear Medicine Market Outlook Report. Compared to the 2018 Nuclear Medicine Market Outlook Report, respondents are more optimistic about procedure volume and less pessimistic about revenue, reimbursement and net income, indicating an improvement in sentiment for centers utilizing Nuclear Medicine (NM) systems.<\/p>\n<p>\nAs of early 2022 COVID-19 continued to have an impact on NM operations, with 11% of respondents indicating it as having a &#8220;high impact&#8221; and 35% stating a &#8220;medium impact&#8221; in their facilities. The impact was primarily driven by requirements for technologists to wear PPE, cancellations or no-shows of appointments due to fear of exposure to COVID and\/or stay at home guidelines and by declines in patient volumes.<\/p>\n<p>\nSupply chain challenges associated with COVID-19 have resulted in 14% of sites that use radiopharmaceuticals indicating there have been changes in how they order NM radiopharmaceuticals. These changes include changes to order frequency and timing as well as reduced dosing.<\/p>\n<p>\nNuclear medicine departments continue to prioritize improving patient satisfaction with their NM experience and satisfying the needs of referring physicians according to the 2022 study. These priorities are closely followed by a focus on managing staffing levels to meet patient volume and scheduling needs, obtaining\/maintaining Nuclear Medicine department accreditation and improving NM department workflow and productivity.<\/p>\n<p>\nCurrently, an estimated 25% of nuclear medicine sites perform radionuclide therapy procedures. This percentage increases to 45-65% of sites performing these procedures when only considering 200+ bed hospitals.<\/p>\n<p>\nMost fixed NM cameras are currently installed in hospitals (57%) with 43% in non-hospital locations. Within non-hospital locations, 74% of the 43% non-hospital locations (32% of total) are physician office locations.<\/p>\n<p>\nThe installed base of fixed NM cameras increased slightly, by 2% to 14,860 units, compared to the 2018 study, driven primarily by an 11.9% increase in installations at non-hospital sites.<\/p>\n<p>\nIn 2022, a combined 41% of sites are &#8220;Yes&#8221; or &#8220;Maybe&#8221; planning to purchase NM cameras over the next three years. Indicating NM camera purchase intent is down from 53% of sites in 2018 and in line with 40% of sites in 2015.<\/p>\n<p>\nThe 2022 Nuclear Medicine Market Outlook Report explores market trends in U.S. hospitals and imaging centers, including procedure volume, manufacture-installed base features and share, the use of OEM vs. third-party service providers, purchase plans, brand loyalty and site operations characteristics.<\/p>\n<p>\nThe 2022 Nuclear Medicine Market Outlook Report was published in June 2022 and is based on responses from 338 radiology\/Nuclear Medicine administrators who participated in the nationwide survey in February &#8211; April 2022. Their responses have been projected to the analyst&#8217;s-identified universe of hospitals and imaging centers in the U.S. that use Nuclear Medicine systems to perform Nuclear Medicine imaging, and the report provides market forecast scenarios addressing the Nuclear Medicine unit market in the United States for 2021-2024. Vendors covered in this report include Siemens, GE, Philips, Canon, Digirad, Spectrum Dynamics and more.<\/p>\n<p>\n<strong>Key Topics Covered:<\/strong><\/p>\n<ul>\n<li>\nBackground and Objectives<\/li>\n<li>\nNuclear Medicine Market Outlook Executive Summary<\/li>\n<li>\nMethodology<\/li>\n<li>\nNuclear Medicine Department Priorities &amp; Future Outlook<\/li>\n<li>\nCOVID-19 Impact Now and the Future<\/li>\n<li>\nNuclear Medicine Patient Study Volume<\/li>\n<li>\nRadiopharmaceuticals &amp; Pharmacological Stress Agents<\/li>\n<li>\nNuclear Medicine Camera Installed Base<\/li>\n<li>\nNuclear Medicine Camera Purchase Plans &amp; Replacement Cycle<\/li>\n<li>\nDemographics &amp; Site Operations Characteristics<\/li>\n<\/ul>\n<p>\n<strong>Market Research Methodology<\/strong><\/p>\n<p>\nThis report utilizes the results from a hosted online survey conducted in February\/April 2022 with 338 NM administrators, supervisors, and chief technologists from a random sample of hospitals and imaging centers in the US.<\/p>\n<p>\nFor more information about this report visit <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5758407\/u-s-nuclear-medicine-market-outlook-report?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=3wr5ql&amp;utm_campaign=1837970+-+U.S+Nuclear+Medicine+Market+Outlook+Report+2022-2024+Featuring+Siemens%2C+GE%2C+Philips%2C+Canon%2C+Digirad%2C+Spectrum+Dynamics+and+more&amp;utm_exec=shbe20prd\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.researchandmarkets.com\/r\/3vtqif<\/a><\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nResearchAndMarkets.com<br \/>\n<br \/>Laura Wood, Senior Press Manager<br \/>\n<br \/><a target=\"_blank\" href=\"ma&#105;&#108;&#116;&#x6f;&#x3a;&#x70;&#x72;es&#115;&#64;&#114;&#x65;&#x73;&#x65;&#x61;rc&#104;&#97;&#110;&#x64;&#x6d;&#x61;&#x72;ke&#116;&#115;&#46;&#x63;&#x6f;&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">&#x70;&#114;&#x65;&#115;s&#x40;&#114;e&#x73;&#101;&#x61;&#x72;c&#x68;&#97;n&#x64;&#109;&#x61;&#x72;k&#x65;&#116;s&#x2e;&#99;o&#x6d;<\/a><br \/>For E.S.T Office Hours Call 1-917-300-0470<br \/>\n<br \/>For U.S.\/ CAN Toll Free Call 1-800-526-8630<br \/>\n<br \/>For GMT Office Hours Call +353-1-416-8900<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;2022 U.S Nuclear Medicine Market Outlook Report&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The 2022 Nuclear Medicine Market Outlook examines nuclear medicine procedure volumes, purchase plans, and buying criteria for future nuclear medicine purchases. Learn how NM administrators feel about their department&#8217;s future outlook and how they prioritize their goals in light &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/u-s-nuclear-medicine-market-outlook-report-2022-2024-featuring-siemens-ge-philips-canon-digirad-spectrum-dynamics-and-more-researchandmarkets-com\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-55659","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>U.S Nuclear Medicine Market Outlook Report 2022-2024 Featuring Siemens, GE, Philips, Canon, Digirad, Spectrum Dynamics and more - ResearchAndMarkets.com - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/u-s-nuclear-medicine-market-outlook-report-2022-2024-featuring-siemens-ge-philips-canon-digirad-spectrum-dynamics-and-more-researchandmarkets-com\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"U.S Nuclear Medicine Market Outlook Report 2022-2024 Featuring Siemens, GE, Philips, Canon, Digirad, Spectrum Dynamics and more - ResearchAndMarkets.com - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;2022 U.S Nuclear Medicine Market Outlook Report&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The 2022 Nuclear Medicine Market Outlook examines nuclear medicine procedure volumes, purchase plans, and buying criteria for future nuclear medicine purchases. Learn how NM administrators feel about their department&#8217;s future outlook and how they prioritize their goals in light ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/u-s-nuclear-medicine-market-outlook-report-2022-2024-featuring-siemens-ge-philips-canon-digirad-spectrum-dynamics-and-more-researchandmarkets-com\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-04-11T09:03:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230411005547\/en\/1760504\/21\/logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/u-s-nuclear-medicine-market-outlook-report-2022-2024-featuring-siemens-ge-philips-canon-digirad-spectrum-dynamics-and-more-researchandmarkets-com\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/u-s-nuclear-medicine-market-outlook-report-2022-2024-featuring-siemens-ge-philips-canon-digirad-spectrum-dynamics-and-more-researchandmarkets-com\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"U.S Nuclear Medicine Market Outlook Report 2022-2024 Featuring Siemens, GE, Philips, Canon, Digirad, Spectrum Dynamics and more &#8211; ResearchAndMarkets.com\",\"datePublished\":\"2023-04-11T09:03:10+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/u-s-nuclear-medicine-market-outlook-report-2022-2024-featuring-siemens-ge-philips-canon-digirad-spectrum-dynamics-and-more-researchandmarkets-com\\\/\"},\"wordCount\":949,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/u-s-nuclear-medicine-market-outlook-report-2022-2024-featuring-siemens-ge-philips-canon-digirad-spectrum-dynamics-and-more-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230411005547\\\/en\\\/1760504\\\/21\\\/logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/u-s-nuclear-medicine-market-outlook-report-2022-2024-featuring-siemens-ge-philips-canon-digirad-spectrum-dynamics-and-more-researchandmarkets-com\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/u-s-nuclear-medicine-market-outlook-report-2022-2024-featuring-siemens-ge-philips-canon-digirad-spectrum-dynamics-and-more-researchandmarkets-com\\\/\",\"name\":\"U.S Nuclear Medicine Market Outlook Report 2022-2024 Featuring Siemens, GE, Philips, Canon, Digirad, Spectrum Dynamics and more - ResearchAndMarkets.com - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/u-s-nuclear-medicine-market-outlook-report-2022-2024-featuring-siemens-ge-philips-canon-digirad-spectrum-dynamics-and-more-researchandmarkets-com\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/u-s-nuclear-medicine-market-outlook-report-2022-2024-featuring-siemens-ge-philips-canon-digirad-spectrum-dynamics-and-more-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230411005547\\\/en\\\/1760504\\\/21\\\/logo.jpg\",\"datePublished\":\"2023-04-11T09:03:10+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/u-s-nuclear-medicine-market-outlook-report-2022-2024-featuring-siemens-ge-philips-canon-digirad-spectrum-dynamics-and-more-researchandmarkets-com\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/u-s-nuclear-medicine-market-outlook-report-2022-2024-featuring-siemens-ge-philips-canon-digirad-spectrum-dynamics-and-more-researchandmarkets-com\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/u-s-nuclear-medicine-market-outlook-report-2022-2024-featuring-siemens-ge-philips-canon-digirad-spectrum-dynamics-and-more-researchandmarkets-com\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230411005547\\\/en\\\/1760504\\\/21\\\/logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230411005547\\\/en\\\/1760504\\\/21\\\/logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/u-s-nuclear-medicine-market-outlook-report-2022-2024-featuring-siemens-ge-philips-canon-digirad-spectrum-dynamics-and-more-researchandmarkets-com\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"U.S Nuclear Medicine Market Outlook Report 2022-2024 Featuring Siemens, GE, Philips, Canon, Digirad, Spectrum Dynamics and more &#8211; ResearchAndMarkets.com\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"U.S Nuclear Medicine Market Outlook Report 2022-2024 Featuring Siemens, GE, Philips, Canon, Digirad, Spectrum Dynamics and more - ResearchAndMarkets.com - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/u-s-nuclear-medicine-market-outlook-report-2022-2024-featuring-siemens-ge-philips-canon-digirad-spectrum-dynamics-and-more-researchandmarkets-com\/","og_locale":"en_US","og_type":"article","og_title":"U.S Nuclear Medicine Market Outlook Report 2022-2024 Featuring Siemens, GE, Philips, Canon, Digirad, Spectrum Dynamics and more - ResearchAndMarkets.com - Pharma Trend","og_description":"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;2022 U.S Nuclear Medicine Market Outlook Report&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The 2022 Nuclear Medicine Market Outlook examines nuclear medicine procedure volumes, purchase plans, and buying criteria for future nuclear medicine purchases. Learn how NM administrators feel about their department&#8217;s future outlook and how they prioritize their goals in light ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/u-s-nuclear-medicine-market-outlook-report-2022-2024-featuring-siemens-ge-philips-canon-digirad-spectrum-dynamics-and-more-researchandmarkets-com\/","og_site_name":"Pharma Trend","article_published_time":"2023-04-11T09:03:10+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230411005547\/en\/1760504\/21\/logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/u-s-nuclear-medicine-market-outlook-report-2022-2024-featuring-siemens-ge-philips-canon-digirad-spectrum-dynamics-and-more-researchandmarkets-com\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/u-s-nuclear-medicine-market-outlook-report-2022-2024-featuring-siemens-ge-philips-canon-digirad-spectrum-dynamics-and-more-researchandmarkets-com\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"U.S Nuclear Medicine Market Outlook Report 2022-2024 Featuring Siemens, GE, Philips, Canon, Digirad, Spectrum Dynamics and more &#8211; ResearchAndMarkets.com","datePublished":"2023-04-11T09:03:10+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/u-s-nuclear-medicine-market-outlook-report-2022-2024-featuring-siemens-ge-philips-canon-digirad-spectrum-dynamics-and-more-researchandmarkets-com\/"},"wordCount":949,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/u-s-nuclear-medicine-market-outlook-report-2022-2024-featuring-siemens-ge-philips-canon-digirad-spectrum-dynamics-and-more-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230411005547\/en\/1760504\/21\/logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/u-s-nuclear-medicine-market-outlook-report-2022-2024-featuring-siemens-ge-philips-canon-digirad-spectrum-dynamics-and-more-researchandmarkets-com\/","url":"https:\/\/pharma-trend.com\/en\/u-s-nuclear-medicine-market-outlook-report-2022-2024-featuring-siemens-ge-philips-canon-digirad-spectrum-dynamics-and-more-researchandmarkets-com\/","name":"U.S Nuclear Medicine Market Outlook Report 2022-2024 Featuring Siemens, GE, Philips, Canon, Digirad, Spectrum Dynamics and more - ResearchAndMarkets.com - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/u-s-nuclear-medicine-market-outlook-report-2022-2024-featuring-siemens-ge-philips-canon-digirad-spectrum-dynamics-and-more-researchandmarkets-com\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/u-s-nuclear-medicine-market-outlook-report-2022-2024-featuring-siemens-ge-philips-canon-digirad-spectrum-dynamics-and-more-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230411005547\/en\/1760504\/21\/logo.jpg","datePublished":"2023-04-11T09:03:10+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/u-s-nuclear-medicine-market-outlook-report-2022-2024-featuring-siemens-ge-philips-canon-digirad-spectrum-dynamics-and-more-researchandmarkets-com\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/u-s-nuclear-medicine-market-outlook-report-2022-2024-featuring-siemens-ge-philips-canon-digirad-spectrum-dynamics-and-more-researchandmarkets-com\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/u-s-nuclear-medicine-market-outlook-report-2022-2024-featuring-siemens-ge-philips-canon-digirad-spectrum-dynamics-and-more-researchandmarkets-com\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230411005547\/en\/1760504\/21\/logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230411005547\/en\/1760504\/21\/logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/u-s-nuclear-medicine-market-outlook-report-2022-2024-featuring-siemens-ge-philips-canon-digirad-spectrum-dynamics-and-more-researchandmarkets-com\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"U.S Nuclear Medicine Market Outlook Report 2022-2024 Featuring Siemens, GE, Philips, Canon, Digirad, Spectrum Dynamics and more &#8211; ResearchAndMarkets.com"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/55659","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=55659"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/55659\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=55659"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=55659"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=55659"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}